4/A: AMN Healthcare Officer Amends Stock Ownership Filing

Sentiment:

Insider Transaction Amendment


AMN Healthcare's Chief Information and Digital Officer, Mark Christopher Hagan, filed an amended Form 4 to correct an overstatement in his previously reported derivative securities ownership.

Summary

  • Mark Christopher Hagan, Chief Information and Digital Officer of AMN Healthcare Services Inc. (AMN), filed an amended Form 4.
  • The amendment corrects an administrative error in the original Form 4 filed on January 16, 2026, which overstated the amount of derivative securities beneficially owned by 36,828 shares.
  • Following the reported transactions, Hagan beneficially owned 36,828 derivative securities, not 73,656 as previously reported.
  • On January 15, 2026, Hagan acquired 1,433, 2,248, and 6,632 shares of common stock through the vesting of Restricted Stock Units (RSUs) granted under the AMN Healthcare 2017 Equity Plan.
  • Concurrently, 591, 926, and 2,622 shares of common stock were disposed of to cover tax withholding obligations at a price of $19.55 per share.
  • Hagan also acquired 36,828 Restricted Stock Units on January 15, 2026, under the AMN Healthcare 2025 Equity Plan, which vest in three tranches on the first, second, and third anniversaries of the grant date.
  • The RSUs represent a contingent right to receive one share of AMN Common Stock and do not have an expiration date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It primarily serves to correct an administrative error in a previous insider transaction report and details routine executive compensation activities, neither of which typically indicates a significant positive or negative shift for the company.

Positives

  • Mark Christopher Hagan acquired a total of 10,313 shares of common stock through the vesting of previously granted Restricted Stock Units, indicating value realization from his compensation plan.
  • A new grant of 36,828 Restricted Stock Units on January 15, 2026, demonstrates continued long-term incentive alignment with the company's performance.

Negatives

  • A total of 4,139 shares of common stock were disposed of at $19.55 per share to cover tax withholding obligations, reducing direct beneficial ownership.

Future Outlook

The Restricted Stock Units granted on January 15, 2026, are scheduled to vest in three tranches on the first, second, and third anniversaries of the grant date, contingent on the grantee's provision of three periods of credited service.

Industry Context

StockSavvy.ai notes that Form 4/A filings are standard regulatory disclosures for insider transactions, providing transparency into executive stock ownership changes. These filings are common across all industries for publicly traded companies when officers or directors acquire or dispose of company stock, often due to compensation plans like RSU vesting.

Stakeholder Impact

  • Shareholders: Provides updated and accurate information regarding the beneficial ownership of a key executive, ensuring transparency in insider holdings.

Key Dates

DateDescription
01/15/2023Grant date for a tranche of Restricted Stock Units that vest over three years.
01/15/2024Grant date for a tranche of Restricted Stock Units that vest over three years.
01/15/2025Grant date for a tranche of Restricted Stock Units that vest over three years.
01/15/2026Transaction date for RSU vesting, tax withholding, and new RSU grant.
01/16/2026Date of original Form 4 filing that contained an administrative error.
01/29/2026Date of signature for the amended Form 4 filing.

Keywords

AMN Healthcare, Form 4/A, Insider Transaction, Restricted Stock Units, Executive Compensation, Stock Ownership, AMN, Officer

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.